AlphaFold predicted structure
ALDOA · P04075

Mean pLDDT
96.4/ 100
Very high
364 residues
Confidence breakdown
- Very high(≥ 90)93%
- Confident(70–90)4%
- Low(50–70)3%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
aldolase, fructose-bisphosphate A
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalCytopenias and congenital anaemias
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalGlycogen storage disease
BIALLELIC, autosomal or pseudoautosomalKetotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalRare anaemia
BIALLELIC, autosomal or pseudoautosomal+4 more panels — install the extension to see the full list inline on any page.
glycogen storage disease due to aldolase A deficiency
disorder of glycogen metabolism
Glycogen storage disease due to glycogenin deficiency
neurodegenerative disease
hereditary disease
ovarian neoplasm
hepatocellular carcinoma
neoplasm
colorectal carcinoma
cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Fructose-bisphosphate aldolase A
Catalyzes the reversible conversion of beta-D-fructose 1,6-bisphosphate (FBP) into two triose phosphate and plays a key role in glycolysis and gluconeogenesis (PubMed:14766013). In addition, also functions as a scaffolding protein (By similarity). In response to glucose deprivation, FBP dissociates from aldolase and acts as an adapter that promotes AMP-activated protein kinase (AMPK) activity: mechanistically, associates with transient receptor potential channels TrpV (TRPV1-TRPV4), promoting inhibition of the V-ATPase complex on lysosomes and AMPK activation via the AXIN1-STK11/LKB1 axis (By similarity)
ALDOA · P04075

Mean pLDDT
96.4/ 100
Very high
364 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0